Amgen Inc. sell Rothschild & Co Redburn
Start price
18.02.26
/
50%
€314.70
Target price
18.02.27
€168.84
Performance (%)
-6.41%
Price
19.06.26
€292.00
Summary
This prediction is currently active. With a performance of -6.41%, the SELL prediction for Amgen Inc. by Rothschild___Co_Redb is down slightly. A total of €2.52 was paid as dividends for this prediction. This prediction currently runs until 18.02.27. The prediction end date can be changed by Rothschild___Co_Redb at any time. Rothschild___Co_Redb has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | -4.871% | -4.871% |
| iShares Core DAX® | 1.352% | 2.740% |
| iShares Nasdaq 100 | 3.277% | 6.507% |
| iShares Nikkei 225® | 7.434% | 17.832% |
| iShares S&P 500 | 1.702% | 3.099% |
Comments by Rothschild___Co_Redb for this prediction
In the thread Amgen Inc. diskutieren
Amgen (NASDAQ:AMGN) had its price target raised by analysts at Rothschild & Co Redburn from $180.00 to $200.00. They now have a "sell" rating on the stock.
Ratings data for AMGN provided by MarketBeat